| 摘要 |
<p>The present invention provides new organic compounds of the following formula:
wherein A, L1, B, L2 and E are as defined in the description of the invention, that are useful for treating conditions or disorders associated with DGAT1 activity, particularly type 2 diabetes, and pharmaceutical compositions and combinations comprising such compounds.</p> |
